These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29958097)

  • 1. Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the future.
    Karamouzis MV; Papavassiliou AG
    Expert Opin Investig Drugs; 2018 Jul; 27(7):569-572. PubMed ID: 29958097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.
    Kyi C; Postow MA
    Immunotherapy; 2016 Jun; 8(7):821-37. PubMed ID: 27349981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting immuno-oncology-based drug combinations - what should we be considering?
    Festino L; Vanella V; Trojaniello C; Ascierto PA
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):971-985. PubMed ID: 30169990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.
    Pico de Coaña Y; Choudhury A; Kiessling R
    Trends Mol Med; 2015 Aug; 21(8):482-91. PubMed ID: 26091825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frontiers in oncology: Immune checkpoint inhibitors in combination therapy.
    Romano G; Gawlinski A
    Drugs Today (Barc); 2017 Feb; 53(2):103-115. PubMed ID: 28387388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination Therapy of Immune Checkpoint Inhibitors].
    Kitano S
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):727-732. PubMed ID: 28912397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
    Hu ZI; Ho AY; McArthur HL
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer.
    Hughes PE; Caenepeel S; Wu LC
    Trends Immunol; 2016 Jul; 37(7):462-476. PubMed ID: 27216414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy.
    Zhao H; Li Y; Wei D; Luo H
    J Immunol Res; 2018; 2018():3673295. PubMed ID: 30406152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
    Terranova-Barberio M; Thomas S; Munster PN
    Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapy].
    Hatae R; Chamoto K
    Rinsho Ketsueki; 2016; 57(10):2224-2231. PubMed ID: 27795534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination strategies in melanoma therapy.].
    Spagnolo F
    Recenti Prog Med; 2017 Dec; 108(12):503-507. PubMed ID: 29297899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propelling Immunotherapy Combinations Into the Clinic.
    Tchekmedyian N; Gray JE; Creelan BC; Chiappori AA; Beg AA; Soliman H; Perez BA; Antonia SJ
    Oncology (Williston Park); 2015 Dec; 29(12):990-1002. PubMed ID: 26680224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combinations of chemotherapy or radiotherapy with checkpoint inhibitors].
    Ghiringhelli F
    Biol Aujourdhui; 2018; 212(3-4):77-79. PubMed ID: 30973135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition.
    Lau PK; Ascierto PA; McArthur G
    Curr Opin Immunol; 2016 Apr; 39():30-8. PubMed ID: 26765776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial Cancer Immunotherapies.
    Hellmann MD; Friedman CF; Wolchok JD
    Adv Immunol; 2016; 130():251-77. PubMed ID: 26923003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.